Fujita Koji

Affiliation and department：

Research field (1)： Gastroenterology

Research keywords (1)： Hepatology

Research theme for competitive and other funds (11)：

2022 - 2025 Functional analysis of miRNA in anti-cancer drug-resistance of hepatocellular carcinoma
2022 - 2025 Examination of the effect of combination therapy of galectin-9 and epigallocatechin gallate on hepatocellular carcinoma
2020 - 2023 microRNA-6126によるHBV増殖抑制機構の解明
2019 - 2022 Anti-tumor effect of Galectin-9 on metastatic hepatocellular carcinoma and its microRNA basis
2019 - 2022 生活習慣病薬による大腸癌の抗腫瘍作用: 新規化学予防薬としての降圧薬ARBの関与

Show all

Papers (254)：

Koji Fujita, Mari Yamada, Asahiro Morishita, Masafumi Ono, Takashi Himoto, Hideki Kobara, Tsutomu Masaki. Cabozantinib inhibits the growth of lenvatinib-resistant hepatoma cells restoring FTCD expression. Biochemical pharmacology. 2024. 226. 116321-116321
Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Koji Fujita, Tsutomu Masaki, Hideki Kobara. The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion. Cancers. 2024. 16. 14
Shima Mimura, Masafumi Ono, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Seiko Kagawa, et al. A Case of Chronic Hepatitis B in which HBs Antigen Seroclearance was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up. Internal medicine (Tokyo, Japan). 2024
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Koji Fujita, Takako Nomura, Asahiro Morishita, et al. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis. Scientific reports. 2024. 14. 1. 10784-10784
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, et al. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients. BMC gastroenterology. 2024. 24. 1. 123-123

ｍore...

MISC (93)：

田所智子, 谷丈二, 正木勉, 中原麻衣, 大浦杏子, 藤田浩二, 森下朝洋. 免疫チェックポイント阻害剤投与に起因する自己免疫性肝疾患の臨床的特徴. 肝臓. 2021. 62. Supplement 1
田所智子, 谷丈二, 正木勉, 中谷夏帆, 中原麻衣, 大浦杏子, 藤田浩二, 森下朝洋. 免疫チェックポイント阻害薬投与後肝障害の臨床的検討. 日本消化器病学会雑誌(Web). 2021. 118
米山弘人, 岩間久和, 森下朝洋, 谷丈二, 野村貴子, 藤田浩二, 田所智子, 大浦杏子, 三村志麻, 中原麻衣, et al. DAA治療によるウイルス排除後にも肝炎が持続あるいは再燃するC型肝炎患者の血清マイクロRNAの解析. 日本消化器病学会雑誌(Web). 2020. 117
藤田浩二, 大浦杏子, 野村貴子, 米山弘人, 森下朝洋, 樋本尚志, 正木勉. 肝疾患の診断と治療慢性C型肝炎におけるALBI scoreの臨床的意義の検討. 日本消化器病学会四国支部例会プログラム・抄録集. 2019. 111回. 45-45
佐藤雄大, 大浦杏子, 琢磨慧, 中原麻衣, 田所智子, 藤田浩二, 野村貴子, 谷丈二, 森下朝洋, 米山弘人, et al. 高齢者肝細胞癌治療と予後関連因子の検討 15年間の単一施設での検討. 日本消化器病学会四国支部例会プログラム・抄録集. 2019. 111回. 77-77

ｍore...

Education (2)：

Professional career (1)：

Work history (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page